María Ángeles Vaz-Salgado
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 04, 2025
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.María Ángeles Vaz-Salgado, Sonia Del Barco, Juan Manuel Sepúlveda
|Oct 20, 2025
Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteria.Maria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl
|Aug 04, 2025
Oligodendrogliomas: findings after classifying the same cohort using pre- and post-World Health Organization (WHO) 2021 criteria.Maria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl
|Apr 25, 2024
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).María Ángeles Vaz-Salgado, Belén Cigarral García, Isaura Fernández Pérez
|Jun 06, 2022
Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot study.María Angeles Vaz Salgado, Julie Earl, Victor Rodriguez Berrocal
|Jul 10, 2021
Reply to: Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better?Carmen Balana, Chen Sun, Maria Angeles Vaz
Pageof 1
Frequent Collaborators
3 joint publications
Julie Earl
2 joint publications
Carmen Balana
2 joint publications
Juan Manuel Sepulveda-Sanchez
2 joint publications
Yolanda Ruano
2 joint publications
Aurelio Hernández-Lain
2 joint publications
Hector Pian
2 joint publications
Jacqueline Gutierrez
2 joint publications
Juan M Sepulveda
1 joint publications
Chen Sun
1 joint publications
Anna Esteve
